Stock earnings page

4D Molecular Therapeutics, Inc. (FDMT)

Track the next or latest earnings date for 4D Molecular Therapeutics, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.

View this earnings week Open in the app

Recent earnings news

Strength Seen in 4D Molecular Therapeutics (FDMT): Can Its 7.9% Jump Turn into More Strength?
ca.finance.yahoo.com · 2 weeks ago

4D Molecular Therapeutics (FDMT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

4D Molecular Therapeutics Secures $200 Million Loan Facility - TipRanks.com
www.tipranks.com · 1 week ago

According to Spark, TipRanks’ AI Analyst, FDMT is a Neutral. The score is held back primarily by weak financial performance—large ongoing losses and substantial cash burn despite improved revenue scale—partly offset by a low-debt balance sheet. Technicals are a key positive with the stock trading ab…

FDMT Stock | 4D Molecular Therapeutics Price, Quote, News & Analysis - TipRanks.com
www.tipranks.com · April 24, 2026

Track FDMT Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. Get 4D Molecular Therapeutics news, earnings, and stock analysis — all in one place at TipRanks.

FDMT Earnings: Latest Report, Earnings Call & Financials
public.com · Recent

Following the last earnings report on May 7, 2026, FDMT's stock price moved — from — to —.

4DMT completes 4FRONT-2 enrollment in wet AMD | FDMT Stock News
www.stocktitan.net · 1 week ago

Enrollment finished about 4 months early in 4FRONT-2, which over-enrolled above 500 patients. Topline data is due in H2 2027.

Latest earnings date

Mar 20, 2026

Time not specified

Fiscal quarter: 2025-12-31

EPS estimate: -$0.53

Revenue estimate: N/A

Market cap: $491.93M

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week

Date	Quarter	Report window	EPS est.	Revenue est.
Mar 20, 2026	2025-12-31	Time not specified	-$0.53	N/A
Feb 27, 2026	2025-12-31	Time not specified	-$0.53	N/A